Keyphrases
Improved Outcomes
100%
Chronic Stroke
100%
Glypican
100%
Chondroitinase ABC
100%
Heparan Sulfate Proteoglycans
100%
Neurocan
62%
Immunoreactivity
25%
Growth Inhibition
12%
Functional Outcome
12%
Cerebral Ischemia
12%
Growth Factors
12%
Brain-derived Neurotrophic Factor
12%
Clinical Improvement
12%
Behavioral Improvement
12%
Glial Fibrillary Acidic Protein
12%
Experimental Stroke
12%
Transient Middle Cerebral Artery Occlusion (tMCAO)
12%
Fibroblast Growth factor-2 (FGF-2)
12%
Microtubule-associated Protein 2 (MAP2)
12%
Histological Outcome
12%
Ischemic Brain Injury
12%
Chondroitin Sulfate Proteoglycans
12%
Peri-infarct Region
12%
Neurotrophic Factor Expression
12%
Anatomical Outcome
12%
Chronic Phase
12%
Chemical Constraints
12%
Infarct
12%
Chondroitin Sulfate
12%
Neurite Extension
12%
Physical Constraints
12%
Glial Scar
12%
Neuritogenesis
12%
Peri-infarct
12%
Growth-stimulating
12%
Cortical Neuron Culture
12%
Neuroscience
Glypican
100%
Proteoheparan Sulfate
100%
N Acetylgalactosamine 4 Sulfatase
100%
Cerebrovascular Accident
100%
Neurocan
62%
Brain Ischemia
12%
Brain-Derived Neurotrophic Factor
12%
Growth Factor
12%
Middle Cerebral Artery
12%
Glial Fibrillary Acidic Protein
12%
Basic Fibroblast Growth Factor
12%
Microtubule Associated Protein 2
12%
Neurite
12%
Proteochondroitin Sulfate
12%
Neurotrophic Factor Expression
12%
Chondroitin Sulfate
12%
Neuritogenesis
12%
Biochemistry, Genetics and Molecular Biology
Proteoglycan
100%
Glypican
100%
Heparan Sulfate
100%
Neurocan
62%
Immunoreactivity
25%
Enzyme
12%
Glial Fibrillary Acidic Protein
12%
Growth Factor
12%
Microtubule-Associated Protein 2
12%
Mediator
12%
Chondroitin Sulfate Proteoglycan
12%
Brain-Derived Neurotrophic Factor
12%
Basic Fibroblast Growth Factor
12%
Brain Cell Culture
12%
Neurotrophic Factor Expression
12%
Chondroitin Sulfate
12%